Pharmacy Practice - Science topic

I think that a relevant symbol that could represent our future profession is the 'Pharmaceutical Care Compass.' This symbolizes the pharmacist's role in providing patient-centered care. It reflects our expertise in medication management, personalized recommendations, and collaboration with other healthcare professionals.

In most pharmacological journals, publication is free of charge for authors (example: FCP https://onlinelibrary.wiley.com/journal/14728206). Exceptions are generally those journals that offer Open Access (OA) to their articles (the same journal may be hybrid: offering a choice between OA and the classic closed model).

I am not aware of a list of journals that meet your criteria, but a first approach can be to look at the journals indexed in Web Of Science: https://mjl.clarivate.com/home

Dear colleque,

Thank you very much for intresting question.

I shoud inform you that I have the book only related with pediatric disseases because I am pediatration and delivered lectures, but my articles research related with Clinical Pharmacology because of my interest in this field of medicine.

Please have look on our(Eminent Biosciences (EMBS)) collaborations.. and let me know if interested to associate with us

Here is our lab page: https://www.eminentbio.com/home/members

Here is our publication: https://www.eminentbio.com/home/Publication

Our recent publications In collaborations with industries and academia in India and world wide.

Our Lab EMBS's Publication In collaboration with Universidad Tecnológica Metropolitana, Santiago, Chile. Publication Link: https://pubmed.ncbi.nlm.nih.gov/33397265/

Our Lab EMBS's Publication In collaboration with Moscow State University , Russia. Publication Link: https://pubmed.ncbi.nlm.nih.gov/32967475/

Our Lab EMBS's Publication In collaboration with Icahn Institute of Genomics and Multiscale Biology,, Mount Sinai Health System, Manhattan, NY, USA. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/29199918

Our Lab EMBS's Publication In collaboration with University of Missouri, St. Louis, MO, USA. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30457050

Our Lab EMBS's Publication In collaboration with Virginia Commonwealth University, Richmond, Virginia, USA. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27852211

Our Lab EMBS's Publication In collaboration with ICMR- NIN(National Institute of Nutrition), Hyderabad Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/23030611

Our Lab EMBS's Publication In collaboration with University of Minnesota Duluth, Duluth MN 55811 USA. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27852211

Our Lab EMBS's Publication In collaboration with University of Yaounde I, PO Box 812, Yaoundé, Cameroon. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30950335

Our Lab EMBS's Publication In collaboration with Federal University of Paraíba, João Pessoa, PB, Brazil. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30693065

Our Lab EMBS's Publication In collaboration with collaboration with University of Yaoundé I, Yaoundé, Cameroon. Publication Link: https://pubmed.ncbi.nlm.nih.gov/31210847/

Our Lab EMBS's Publication In collaboration with University of the Basque Country UPV/EHU, 48080, Leioa, Spain. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27852204

Our Lab EMBS's Publication In collaboration with King Saud University, Riyadh, Saudi Arabia. Publication Link: http://www.eurekaselect.com/135585

Our Lab EMBS's Publication In collaboration with NIPER , Hyderabad, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/29053759

Our Lab EMBS's Publication In collaboration with Alagappa University, Tamil Nadu, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30950335

Our Lab EMBS's Publication In collaboration with Jawaharlal Nehru Technological University, Hyderabad , India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/28472910

Our Lab EMBS's Publication In collaboration with C.S.I.R – CRISAT, Karaikudi, Tamil Nadu, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30237676

Our Lab EMBS's Publication In collaboration with Karpagam academy of higher education, Eachinary, Coimbatore , Tamil Nadu, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30237672

Our Lab EMBS's Publication In collaboration with Ballets Olaeta Kalea, 4, 48014 Bilbao, Bizkaia, Spain. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/29199918

Our Lab EMBS's Publication In collaboration with Hospital for Genetic Diseases, Osmania University, Hyderabad - 500 016, Telangana, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/28472910

Our Lab EMBS's Publication In collaboration with School of Ocean Science and Technology, Kerala University of Fisheries and Ocean Studies, Panangad-682 506, Cochin, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27964704

Our Lab EMBS's Publication In collaboration with CODEWEL Nireekshana-ACET, Hyderabad, Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/26770024

Our Lab EMBS's Publication In collaboration with Bharathiyar University, Coimbatore-641046, Tamilnadu, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27919211

Our Lab EMBS's Publication In collaboration with LPU University, Phagwara, Punjab, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/31030499

Our Lab EMBS's Publication In collaboration with Department of Bioinformatics, Kerala University, Kerala. Publication Link: http://www.eurekaselect.com/135585

Our Lab EMBS's Publication In collaboration with Gandhi Medical College and Osmania Medical College, Hyderabad 500 038, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27450915

Our Lab EMBS's Publication In collaboration with National College (Affiliated to Bharathidasan University), Tiruchirapalli, 620 001 Tamil Nadu, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/27266485

Our Lab EMBS's Publication In collaboration with University of Calicut - 673635, Kerala, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/23030611

Our Lab EMBS's Publication In collaboration with NIPER, Hyderabad, India. ) Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/29053759

Our Lab EMBS's Publication In collaboration with King George's Medical University, (Erstwhile C.S.M. Medical University), Lucknow-226 003, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/25579575

Our Lab EMBS's Publication In collaboration with School of Chemical & Biotechnology, SASTRA University, Thanjavur, India Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/25579569

Our Lab EMBS's Publication In collaboration with Safi center for scientific research, Malappuram, Kerala, India. Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/30237672

Our Lab EMBS's Publication In collaboration with Dept of Genetics, Osmania University, Hyderabad Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/25248957

Our Lab EMBS's Publication In collaboration with Institute of Genetics and Hospital for Genetic Diseases, Osmania University, Hyderabad Publication Link: https://www.ncbi.nlm.nih.gov/pubmed/26229292

Sincerely,

Dr. Anuraj Nayarisseri

Principal Scientist & Director,

Eminent Biosciences.

Mob :+91 97522 95342

Most Clinical Pharmacists/Pharmacy Practitioners publish in journals such as Int. J. Pharmacy practice, Int. J. Clinical Pharmacy, Journal of Pharmacy Practice and Research, Research in Social and Administrative Pharmacy etc.

We are a relatively Large profession and publishing in these journals brings our research to the attention of our peers.

Win Winit‑watjana thank you for the comment.

I think now is the best time in history to be a great pharmacist and simultaneously the worst time in history to be a mediocre one. The opportunities are abundant to create transformational value for our clients and/or patients. if you know how to create valuable services for others you will be a great success, if you don't you will be lucky to find a job.

Pharmacists' job-based mindset is a career death sentence. Solve problems for others and you will always be employed.

Dixon,

Thanks for posing the question. To put things in perspective, Pharmacy has NOT always been clinical in the sense that it is today. When I started out in the mid 80s, collaborative practice agreements were essentially non-existent. Pharmacists weren’t allowed to immunize. In most places, pharmacists weren‘t allowed to write in the chart “for liability issues”. Funny how now if a pharmacist does NOT review a patients meds, that neglect is considered liability! I worked in a behavioral health care facility in the 2000s in which pharmacists STILL did not have access to patient lab data! Yes, pharmacy has come a long way since I first started practicing but we still have a long way to go.

Mohamed, check out this journal. You might find it interesting. I’m a review for it: https://commons.pacificu.edu/hip/about.html

Pharmaceutical Care, Medication Therapy Management (MTM), and Pharmacists' Patient Care Process (PPCP) are discussed well in the Elsevier textbook Clinical Pharmacy Education, Practice and Research. Authors include global leaders in MTM and PPCP;

Hi,

Mentioned below books would be great help for early carer researchers.

1. DESIGNING AND CONDUCTING HEALTH SURVEYS; A Comprehensive Guide

2. A Comprehensive Guide: A Comprehensive Guide

There are no guidelines or standards widely accepted for OTC medicines used in community pharmacies, as minor illnesses vary from one region to another. However, you may follow the WHO's brief guidance as you wish. In the UK, three reference books have been used by most pharmacy students and pharmacists:

1. Symptoms in the pharmacy: a guide to the management of common illness. 7th ed. Blenkinsopp A, Paxton P, Blenkinsopp J. Oxford: Wiley-Blackwell; 2014.

*** This book is recommended for pharmacy students and pharmacists, as it provides many good disease and medication points, esp. when to refer patients.

2. Community pharmacy: symptoms, diagnosis and treatment. 4th ed. Rutter P. Edinburgh: Elsevier; 2017.

*** Professor Rutter is an experienced community pharmacist himself and he spent many years writing this book to meet all purposes.

3. Minor illness or major disease. 6th ed. Addison B, Brown A, Edwards R, Gray G. London: Pharmaceutical Press; 2016.

*** It is interesting to see some OTC and P medicines used for both minor and major diseases.

Hope this helps.

Dr Win

Pharmacy practice is a term that was introduced long time ago but just adopted to explain the evolution of pharmacy profession by Hepler and Strand in 1989. The evolution with three stages includes:

1. Traditional pharmacy practice (or product-oriented practice). At this stage, pharmacists are all involved in technical or product-related practice, such as dispensing, inventory control, sterile and non-sterile drug manufacturing, etc.

2. Clinical pharmacy practice (or service-oriented practice). Pharmacists at this stage try to get close to patients on the ward or OPD by providing clinical pharmacy services, e.g. DIS, ADR monitoring, TDM, iv drug admixture, etc.

3. Pharmaceutical care practice (or patient-focused practice). It is called medication therapy managment (MTM) in the US, or medicines management/optimisation in the UK. Pharmacists need to optimize the use of medicines in terms of benefits and risks by working closely with other healthcare professionals and patients.

To put it in short, pharmacy practice nowadays is a broad term that embraces all traditional practices, clinical pharmacy and pharmaceutical care regardless of settings. In the UK, to many pharmacists pharmacy practice is more involved in community pharmacy, whereas clinical pharmacy is mostly hospital-based or GP practice-based.

In developing countries one of the major issues is linked to falsified drugs and fake medicine which results in important health issues in those countries.

Hi Ramesh!

When I was working with a local government hospital in the Philippines, we started our Clinical Pharmacy by engaging key doctors who will approve of the idea of having one. We stressed on medication error prevention (there are a lot of researches available online can help justify this) and patient safety. We also talked to the nursing management and told them on the advantages of having a clinical pharmacist (how having one would make their job easier). This is almost the same strategy we did when we were establishing clinical pharmacy in a private - tertiary hospital in the same country. Do you have unit dose distribution in your hospital?

On how to encourage your pharmacists in the shift from product oriented to patient oriented - This is actually hard to do especially for those older Pharmacists who are already satisfied with what they are currently doing. This is easier to do with the younger ones (based on experience). You can make them realize that soon there will be no more room left for just dispensing pharmacists. There are a lot of dispensing machines that can actually take their place. So the need for this shift is important to make the other healthcare professionals and the patients realize the value of the pharmacy profession.

Being resource limited, you can actually start with patient counselling and drug information service. With that service, communication skills and product information are needed which will not be too expensive. The package inserts and MIMS are tools you can use..etc

Great discussion. You are all invited to Join PharmaHuF on LinkedIn where we are collecting a lot of the evidence concerning this subject. Just request to join and I can approve. 

Since shelf life is determined by testing in the original container, the stability can be impacted as soon as the medicine is taken from the original container, eg highly hygrosopic medicines, soluble medicines, etc. Since generics will have different excipients (and therefore stability), I would imagine that a general rule relating to the active ingredient may not suffice. The only source of information I can think of is stability testing undertaken by the pharma company, which they are often hesitant to provide because it is not in line with their regulatory approval. There are usually local regulations which govern packaging of dosage administration aids, so they will be a good starting point. Also need to think about method of repackaging and timeframe in repackaged aid.

Dear Kazem

Yes you can use our questionnaire attached here but keep in mind to make citation for us once you published your work.

Good luck

Hi, after my span of almost 15 years in hospital pharmacy settings, I have come across  a number of possible reasons why patients do NOT have their discharge prescriptions filled from hospital after a stay in hospital and reasons why they may delay or not fill prescriptions from their community pharmacies (particularly after a hospital stay):

A/ Looking specifically at why patients may not have their hospital discharge medication dispensed: Patients have been known to not fill discharge meds for the following reasons: 1. Lack of education/ counseling on the importance of those meds; 2. time issues to just wanting to get home after a hospital stay and not wanting to wait extra time for discharge meds to be dispensed; 3. Number of days of medications issued via discharge varies in each hospital. Some hospitals dispense between 5 days up to a week's worth of medications and the patient then still needs to obtain further supplies via their community pharmacies. Some prefer to just obtain their whole supply of meds from their community pharmacies. 4. Some hospitals do not even supply the full list of the meds that the patient is currently on. For example, some hospitals in Australia will only supply the 'newly prescribed medication' that the patient has had during the recent stay in hospital and will not supply their regular medications. This becomes confusing for some patients as some may think that the other medications that have not been supplied, may not be as important or may be perceived as not needed in future. 

B/ Looking specifically at why patients may delay non-filling of prescription medication from their community pharmacies after a hospital stay: 1. issues of non-adherence; 2. Lack of time; 3. Cognitive impairment issues; 4. Lack of education/counseling by the health care practitioner regarding the importance of each medication for their continued health; 5. Money issues and cannot afford the cost for the full list of monthly prescription medications (One big concern: Some patients may try to decide which medications are perceived to be more important for their health and therefore only have some medications filled at any given time!)

Of course, the above lists are not limited to these points...

Dear Jorge Ramirez,

Yes of course, the JUPITER trial of originator brand Crestor shows insignificant evidence of reduction in CVD i.e. morbidity and mortality compared to placebo in clinical trial phase III.

Though nobody could assure to minimize the mortality in cardiovascular events with a single lipid lowering agent therapy, that isn't the therapeutics directed. It can only be used to reduce the cardiovascular risks by virtue of all lipid lowering agent.

And the main theme of mine on which I'm trying to attain the attention in the treatment of type-II diabetes associated hypertension. I do believe, here it will show good effects as we observed from some local patients, their compliance is high enough to hold attention towards rosuvastatin rather than atorvastatin in that case.

Thanks with regards,

Arjya

Hi Margaret,

Will send my publications to you this week.

Cheers,

Cherie

Clinical Pharmacists are uniquely trained in therapeutics and provide comprehensive drug management to patients and providers (includes physicians and additional members of the care team). Pharmacist intervention outcomes include economics, health-related quality of life,patient satisfaction, medication appropriateness, adverse drug events (ADEs), and adverse drug reactions (ADRs).